Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders

BACKGROUND: Long-chain fatty acid oxidation disorders (LC-FAOD) are a group of rare inborn errors of metabolism with autosomal recessive inheritance that may cause life-threatening events. Treatment with triheptanoin, a synthetic seven-carbon fatty acid triglyceride compound with an anaplerotic effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zöggeler, Thomas, Stock, Katharina, Jörg-Streller, Monika, Spenger, Johannes, Konstantopoulou, Vassiliki, Hufgard-Leitner, Miriam, Scholl-Bürgi, Sabine, Karall, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807521/
https://www.ncbi.nlm.nih.gov/pubmed/33446227
http://dx.doi.org/10.1186/s13023-020-01635-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807521/
https://www.ncbi.nlm.nih.gov/pubmed/33446227
http://dx.doi.org/10.1186/s13023-020-01635-x

Ejemplares similares